Omnicell (OMCL) Free Cash Flow Growth (5y) (2015 - 2026)
Powered by 
Analysis
Omnicell (OMCL) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.03% |
| Mar 31, 2026 | -4.27% |
| Dec 31, 2025 | -20.40% |
| Sep 30, 2025 | -10.72% |
| Jun 30, 2025 | -3.73% |
| Mar 31, 2025 | -7.73% |
| Dec 31, 2024 | 8.40% |
| Sep 30, 2024 | -23.55% |
| Jun 30, 2024 | 31.11% |
| Mar 31, 2024 | 5.28% |
| Dec 31, 2023 | -7.36% |
| Sep 30, 2023 | 32.14% |
| Jun 30, 2023 | 30.56% |
| Mar 31, 2023 | -22.80% |
| Dec 31, 2022 | 109.60% |
| Sep 30, 2022 | 19.11% |
| Jun 30, 2022 | -27.73% |
| Mar 31, 2022 | -28.22% |
| Dec 31, 2021 | 18.90% |
| Sep 30, 2021 | 48.10% |